Efficacy News and Research

RSS

Future Oncology: Special issue focuses on field of psycho-oncology in cancer care

The Future Science Group published journal, Future Oncology, has released a special issue that examines the field of psycho-oncology, which aims to bring together the biomedical and psychosocial aspects of cancer care.

4 Jan 2017

Chemical modification improves release and availability of insulin, research shows

Replacing a hydrogen atom by an iodine atom in insulin, the hormone retains its efficacy but is available more rapidly to the organism.

3 Jan 2017

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.

3 Jan 2017

A new strategy to fight prostate cancer

A new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) sheds light on a signaling circuit in cells that drives therapy resistance in prostate cancer.

30 Dec 2016

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors.

30 Dec 2016

Studies in non-human primates provide more predictive results in genetic causes of blindness

Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, as shown by the results of a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

29 Dec 2016

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

29 Dec 2016

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

FDA grants permission to assess safety of investigational drug for Alzheimer's disease in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

28 Dec 2016

Kessler Foundation researcher receives grant to identify treatments for cognitive deficits in people with SCI

The three-year federal grant will fund research to identify treatments for cognitive difficulties in persons with spinal cord injury.

27 Dec 2016

Combination of diabetes and hypertension drugs can effectively treat cancer

A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells.

27 Dec 2016

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors.

27 Dec 2016

Novel investigational drug may help restore cardiac function after heart failure

Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure, according to a first-in-man study published today in JACC: Basic to Translational Science.

27 Dec 2016

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved SPINRAZATM (nusinersen) under Priority Review for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

26 Dec 2016

UF researchers play integral role in Ebola vaccine trial

An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.

26 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

Efficacy News and Research

Future Oncology: Special issue focuses on field of psycho-oncology in cancer care

Chemical modification improves release and availability of insulin, research shows

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

A new strategy to fight prostate cancer

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Studies in non-human primates provide more predictive results in genetic causes of blindness

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

FDA grants permission to assess safety of investigational drug for Alzheimer's disease in humans

Kessler Foundation researcher receives grant to identify treatments for cognitive deficits in people with SCI

Combination of diabetes and hypertension drugs can effectively treat cancer

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Novel investigational drug may help restore cardiac function after heart failure

New study shows efficacy of Ebola vaccine in offering protection against disease

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

UF researchers play integral role in Ebola vaccine trial

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

FDA approves first drug to treat children and adults with spinal muscular atrophy

Gambian sleeping sickness could be eliminated in six years in DRC, research reveals

Study discovers critical function of mother's immune cells in resisting preterm birth

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News